- Aptar acquired Sommaplast, a Brazilian oral dosing packaging provider.
- Sommaplast operates from Sao Paulo with over 400 employees.
- Aptar has been manufacturing in Brazil for 25 years.
- The acquisition aims to capitalize on Brazil's growing oral dosing market.
Acquisition Overview
AptarGroup, Inc., a leader in drug and consumer product dosing technologies, has acquired Sommaplast, a Brazilian company specializing in oral dosing pharma packaging solutions. This acquisition aims to strengthen Aptar's presence in Brazil and capitalize on the country's expanding oral dosing market.
Sommaplast's Background
Founded over 20 years ago, Sommaplast operates from a facility in Sao Paulo with a workforce of more than 400 employees. The company is recognized for its strong team, deep customer relationships, and expertise in dosing solutions.
Strategic Expansion
Aptar has been manufacturing in Brazil for 25 years and currently has facilities in Cajamar, Jundiaí, Maringá, and Camaçari. The acquisition of Sommaplast expands Aptar's footprint in Latin America, leveraging shared manufacturing strengths and operational synergies.
Market Potential
The acquisition positions Aptar to benefit from Brazil's fast-growing oral dosing, over-the-counter, and nutraceutical markets, driven by an expanding population, rising middle class, and aging demographic.
